Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ) Identifier:
First received: September 30, 2011
Last updated: August 6, 2016
Last verified: April 2013